Hi there,

If you think Democracy Now!’s reporting is a critical line of defense against war, climate catastrophe and authoritarianism, please make your donation of $10 or more right now. Today, a generous donor will DOUBLE your donation, which means it’ll go 2x as far to support our independent journalism. Democracy Now! is funded by you, and that’s why we’re counting on your donation to keep us going strong. Please give today. Every dollar makes a difference—in fact, gets doubled! Thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


Ex-World Leaders and Nobel Laureates Call on Biden to Waive Patent Rules for COVID Vaccines

HeadlineApr 15, 2021

One hundred seventy-five former heads of state and Nobel laureates are calling on President Biden to back a waiver on World Trade Organization intellectual property rules for COVID-19 vaccines during the pandemic. Nine out of 10 people in most poor countries likely will not receive a vaccine this year, according to the open letter, but an IP waiver would “expand global manufacturing capacity, unhindered by industry monopolies that are driving the dire supply shortages blocking vaccine access.” Signatories include former Liberian President Ellen Johnson Sirleaf, former British Prime Minister Gordon Brown and economist Joseph Stiglitz. Separately, a coalition of 250 organizations, including Amnesty International, Public Citizen and Doctors Without Borders, issued a similar plea to the head of the World Trade Organization. The fate of the international efforts could be decided on May 5 at the next major meeting between WTO members.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation